Clinical Trials List
Protocol NumberHCC
2022-09-01 - 2026-08-31
Others
Recruiting2
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Principal Investigator
Co-Principal Investigator
- 楊宏志 Division of General Internal Medicine
- Shih-Jer Hsu Division of General Internal Medicine
- 林宗哲 Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
- JA-DER LIANG Division of General Internal Medicine
- KAI-WEN HUANG Division of General Surgery
- YU-YUN SHAO Division of Hematology & Oncology
- Chun-Jen Liu Division of General Internal Medicine
- Chia-Hsien Chen Division of Hematology & Oncology
- 曾岱宗 Division of General Internal Medicine
- 蔡巧琳 Division of Hematology & Oncology
- 呂理駿 Division of Hematology & Oncology
- Jia-Horng Kao Division of General Internal Medicine
- 蘇東弘 Division of General Internal Medicine
- Ying-Chun Shen Division of Hematology & Oncology
- TSUNG-HAO LIU Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Principal Investigator
Co-Principal Investigator
- 林群書 Division of Radiation Therapy
- 沈伯鍵 Division of Radiation Therapy
- 洪志杰 Division of General Surgery
- 施宇隆 Digestive System Department
- 陳宣位 Digestive System Department
- 張平穎 Digestive System Department
- 何幸豪 Digestive System Department
- Chang-Ming Chern Division of Radiation Therapy
- 陳登偉 Division of General Surgery
- 何孟興 Division of General Surgery
- 林榮鈞 Digestive System Department
- 張肇丰 Digestive System Department
- 陳佳宏 Digestive System Department
- 黃文彥 Division of Radiation Therapy
- 蘇瑜富 Division of Radiation Therapy
- 詹德全 Division of General Surgery
- 馮安捷 Division of General Surgery
- 黃瑋琛 Digestive System Department
- 楊志偉 Digestive System Department
- 賴學緯 Digestive System Department
- 羅承翔 Division of Radiation Therapy
- 楊仁富 Division of Radiation Therapy
- 樊修龍 Division of General Surgery
- 謝宗保 Division of General Surgery
- 陳保中 Digestive System Department
- 何景良 Digestive System Department
- 張維洲 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
27 participants
-
Global
0 participants